Association between DNA Methylation of the BDNF Promoter Region and Clinical Presentation in Alzheimer's Disease

Dementia and Geriatric Cognitive Disorders Extra

关键词: Epigenetics;    Brain-derived neurotrophic factor;    Alzheimerߣ;    s disease;    BDNF;    DNA methylation;    Neurotrophic factors;   

DOI  :  10.1159/000375367

来源: DOAJ

【 摘 要 】

Background/Aims: In the present study, we examined whether DNA methylation of the brain-derived neurotrophic factor (BDNF) promoter is associated with the manifestation and clinical presentation of Alzheimer's disease (AD). Methods: Of 20 patients with AD and 20 age-matched normal controls (NCs), the DNA methylation of the BDNF promoter (measured using peripheral blood samples) was completely analyzed in 12 patients with AD and 6 NCs. The resulting methylation levels were compared statistically. Next, we investigated the correlation between the DNA methylation levels and the clinical presentation of AD. Results: The total methylation ratio (in %) of the 20 CpG sites was significantly higher in the AD patients (5.08 ± 5.52%) than in the NCs (2.09 ± 0.81%; p Conclusion: These results suggest that the DNA methylation of the BDNF promoter may significantly influence the manifestation of AD and might be associated with its neurocognitive presentation.

【 授权许可】

Unknown